Institutional Cluster

MIRM

Mirum Pharmaceuticals, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed3mo ago
Institutional cluster: 9 buyers, 3 sellers (bullish)
Actionable Insight ▲ Bullish

The broad-based institutional accumulation, especially from passive funds and sovereign wealth, suggests the stock is being added to core portfolios ahead of the volixibat PSC Phase 3 data. However, the 45-day 13F reporting lag means these positions may already be partially unwound. Monitor upcoming Q1 2026 13F filings for confirmation of continued accumulation. The Point72 near-exit is a contrarian signal worth watching.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
MIRM ▲ +1.37% at T+60d
LONG call ✓ call won +1.37% · α vs SPY -3.03% · entry $99.54 → $100.90
Entry anchored
Jun 11, 02:16 PM ET
via exchange tick
T+1d
-0.20%
call -0.20% · α -0.74%
$99.35
settled 4mo ago
T+5d
+2.51%
call +2.51% · α +2.08%
$102.04
settled 4mo ago
T+20d
+28.29%
call +28.29% · α +26.40%
$127.70
settled 3mo ago
T+60d
+1.37%
call +1.37% · α -3.03%
$100.90
settled 24d ago

Executive Summary

A strong institutional buying cluster emerged in MIRM during Q4 2025, with 9 buyers adding $189.1M in net new positions versus 3 sellers reducing by $60.7M. The buying was dominated by mega-passive funds (State Street, BofA, Wells Fargo) and sovereign/asset managers (Norges Bank, Wellington, Deutsche Bank), suggesting broad-based conviction in Mirum's commercial-stage rare-disease portfolio. The cluster aligns with the company's strong revenue growth trajectory from Livmarli and the upcoming Phase 3 readout for volixibat in PSC.

Key Financial Metrics

Direction
accumulating
Buy Value
$391.9M
Sell Value
$60.7M
Net Flow
$128.4M

Institutional Positions

Net institutional flow: $128.4M

▲ Buyers (9)

InstitutionActionChangePosition ValueValue Δ
State StreetADD+59.2%$169.4M$70.6M
BofAADD+82.7%$56.4M$27.7M
Wells FargoDOUBLED+326.5%$9.1M$7.1M
Norges BankNEW—$20.8M$20.8M
Wellington Management GroupADD+56.6%$97.8M$39.8M
Ameriprise FinancialADD+33.7%$21.4M$6.6M
Envestnet Asset ManagementDOUBLED+201.2%$1.6M$1.1M
Deutsche BankNEW—$14.7M$14.7M
Mirae Asset Global InvestmentsDOUBLED+377.5%$733.0K$590.0K

▼ Sellers (3)

InstitutionActionChangePrev ValueValue Δ
InvescoTRIM-36%$7.4M-$2.3M
Point72NEAR_EXIT-75.9%$58.0M-$42.9M
Morgan StanleyTRIM-36.5%$49.1M-$15.5M

Key Facts

  • 9 institutional buyers added $189.1M in net new positions during Q4 2025, while 3 sellers reduced by $60.7M
  • State Street added $70.6M (+59.2% shares), Wellington added $39.8M (+56.6%), Norges Bank initiated a $20.8M new position
  • Point72 made a near-exit, cutting 75.9% of its position ($42.9M sold), while Morgan Stanley trimmed $15.5M (-36.5%)
  • Mega-passive funds (State Street, BofA, Wells Fargo) accounted for $105.4M of the buying, signaling index-driven accumulation
  • Sovereign wealth (Norges Bank) and active asset managers (Wellington, Deutsche Bank) added $75.3M in new/added positions

Financial Impact

9 institutional buyers accumulated $189.1M in net new positions, while 3 sellers reduced holdings by $60.7M, for a net institutional inflow of $128.4M

institutional ownershipfloat demand

Risk Factors

  • 13F data is 45+ days stale; the cluster may have been partially or fully unwound since quarter-end
  • Point72's near-exit ($42.9M sold) suggests a loss of conviction from a sophisticated quant fund
  • Mega-passive buying may reflect index rebalancing rather than fundamental conviction in Mirum's pipeline
  • Volixibat PSC Phase 3 readout is binary — a miss would reverse the accumulation thesis

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (19 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-MIRM-2025-Q4
16 reports for MIRM
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +23.79%Apr 27, 2026
Filters
Rows
Reports for MIRM — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$102.24 $98.82▼ −3.35%▼ −1.39%—
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$98.97 $100.61▲ +1.66%▲ +3.55%—
Aug 11, 2026
7w ago
Insider Cluster
BEARISH ★ 5/10
$98.97 $100.61▼ −1.66%▼ −3.55%—
Aug 10, 2026
7w ago
144
NEUTRAL ★ 3/10
$98.23 $98.30▲ +0.07%▲ +1.13%—
Aug 5, 2026
8w ago
8-K
MIXED ★ 6/10
$94.12 $100.63▲ +6.92%▲ +6.32%—
Jul 8, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$128.57 $105.79▼ −17.72%▼ −20.99%—
Jun 11, 2026
16w ago
Institutional Cluster
BULLISH ★ 6/10
$99.54 $127.70▲ +28.29%▲ +26.40%—
Jun 10, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$94.00 $127.70▲ +35.85%▲ +32.23%—
Jun 2, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.84 $125.59▲ +36.76%▲ +37.76%—
Jun 1, 2026
17w ago
144
NEUTRAL ★ 3/10
$92.17 $120.46▲ +30.69%▲ +32.26%—
Showing 10 of 16

US Market Status

Market Open — Closes in 46m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026